Attached files
file | filename |
---|---|
EX-32 - EXHIBIT 32 - UNIVERSAL BIOSENSORS INC | d292024dex32.htm |
EX-31.1 - EXHIBIT 31.1 - UNIVERSAL BIOSENSORS INC | d292024dex311.htm |
EX-31.2 - EXHIBIT 31.2 - UNIVERSAL BIOSENSORS INC | d292024dex312.htm |
EX-10.20 - EXHIBIT 10.20 - UNIVERSAL BIOSENSORS INC | d292024dex1020.htm |
EX-10.21 - EXHIBIT 10.21 - UNIVERSAL BIOSENSORS INC | d292024dex1021.htm |
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 10-Q/A-1
QUARTERLY REPORT
PURSUANT TO SECTION 13 OR 15 (d) OF
THE SECURITIES EXCHANGE ACT OF 1934
For the quarterly period ended September 30, 2011
Universal Biosensors, Inc.
(Exact name of registrant as specified in its charter)
Delaware | 98-0424072 | |
(State or other jurisdiction of incorporation or organization) |
(I.R.S. Employer Identification Number) | |
Universal Biosensors, Inc. 1 Corporate Avenue, Rowville, 3178, Victoria Australia |
Not Applicable | |
(Address of principal executive offices) | (Zip Code) |
Telephone: +61 3 9213 9000
(Registrants telephone number, including area code)
Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes x No ¨
Indicate by check mark whether the registrant has submitted electronically and posted on its corporate Web site, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files). Yes x No ¨
Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer or a smaller reporting company. See definition of accelerated filer, large accelerated filer and smaller reporting company in Rule 12b-2 of the Exchange Act. (Check one):
Large Accelerated Filer | ¨ | Accelerated Filer | x | |||
Non-Accelerated Filer | ¨ (Do not check if a smaller reporting company) | Smaller reporting company | ¨ |
Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes ¨ No x
Indicate the number of shares outstanding of each of the issuers classes of common stock, as of the latest practicable date: 159,025,161 shares of Common Stock, U.S.$0.0001 par value, outstanding as of November 3, 2011.
Explanatory Note
This amendment to the Form 10-Q for the period ended September 30, 2011 (Form 10-Q) is being filed to reflect the removal of certain redactions from Exhibits 10.20 and 10.21 previously filed under Item 6 of Part II of the Form 10-Q.
Universal Biosensors, Inc.
PART II
Item 6 | Exhibits |
Exhibit |
Description |
Location | ||
10.20 | Collaboration Agreement between Siemens Healthcare Diagnostics, Inc. and Universal Biosensors Pty Ltd | Filed herewith | ||
10.21 | Statement of Work for MAP Feasibility Project | Filed herewith | ||
10.22 | Novation Agreement and First Amendment to the Amended and Restated Master Services and Supply Agreement between LifeScan, Inc, Cilag GmbH International, Universal Biosensors Pty Ltd and Universal Biosensors, Inc. | * | ||
10.23 | Second Amendment to the Amended and Restated Master Services and Supply Agreement between Cilag GmbH International, Universal Biosensors Pty Ltd and Universal Biosensors, Inc. | * | ||
31.1 | Rule 13a-14(a)/15d-14(a) Certification (Principal Executive Officer) | Filed herewith | ||
31.2 | Rule 13a-14(a)/15d-14(a) Certification (Principal Financial Officer) | Filed herewith | ||
32 | Section 1350 Certificate | Furnished herewith | ||
101 | The following materials from the Universal Biosensors, Inc. Quarterly Report on Form 10-Q for the quarter ended September 30, 2011 formatted in Extensible Business Reporting Language (XBRL): (i) the Consolidated Condensed Balance Sheets, (ii) the Consolidated Condensed Statements of Operations, (iii) the Consolidated Condensed Statements of Changes in Stockholders Equity and Comprehensive Income, (iv) the Consolidated Condensed Statements of Cash Flows and (v) the Notes to Consolidated Condensed Financial Statements tagged as blocks of text | As provided in Rule 406T of Regulation S-T, this information is furnished herewith and not filed for purposes of Sections 11 and 12 of the Securities Act of 1933 and Section 18 of the Securities Exchange Act of 1934 |
* | Incorporated by reference to the Companys Form 10-Q for the quarter ending September 30, 2011. |
Universal Biosensors, Inc.
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.
UNIVERSAL BIOSENSORS, INC. (Registrant) | ||||
By: | /s/ Paul Wright | |||
Date: January 31, 2012 | Paul Wright | |||
Principal Executive Officer | ||||
By: | /s/ Salesh Balak | |||
Date: January 31, 2012 | Salesh Balak | |||
Principal Financial Officer |
INDEX TO EXHIBITS
Quarterly Report on Form 10-Q
Dated November 3, 2011
Exhibit No |
Description |
Location | ||
10.20 | Collaboration Agreement between Siemens Healthcare Diagnostics, Inc. and Universal Biosensors Pty Ltd | Filed herewith | ||
10.21 | Statement of Work for MAP Feasibility Project | Filed herewith | ||
10.22 | Novation Agreement and First Amendment to the Amended and Restated Master Services and Supply Agreement between LifeScan, Inc, Cilag GmbH International, Universal Biosensors Pty Ltd and Universal Biosensors, Inc. | * | ||
10.23 | Second Amendment to the Amended and Restated Master Services and Supply Agreement between Cilag GmbH International, Universal Biosensors Pty Ltd and Universal Biosensors, Inc. | * | ||
31.1 | Rule 13a-14(a)/15d-14(a) Certification (Principal Executive Officer) | Filed herewith | ||
31.2 | Rule 13a-14(a)/15d-14(a) Certification (Principal Financial Officer) | Filed herewith | ||
32 | Section 1350 Certificate | Furnished herewith | ||
101 | The following materials from the Universal Biosensors, Inc. Quarterly Report on Form 10-Q for the quarter ended September 30, 2011 formatted in Extensible Business Reporting Language (XBRL): (i) the Consolidated Condensed Balance Sheets, (ii) the Consolidated Condensed Statements of Operations, (iii) the Consolidated Condensed Statements of Changes in Stockholders Equity and Comprehensive Income, (iv) the Consolidated Condensed Statements of Cash Flows and (v) the Notes to Consolidated Condensed Financial Statements tagged as blocks of text |
* | Incorporated by reference to the Companys Form 10-Q for the quarter ended September 30, 2011. |